Joyce Tait
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joyce Tait has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- David Wield
Development Policy and Practice, The Open University, Milton Keynes, UK
3 shared publications - Monica Hoyos Flight
Innogen Institute, University of Edinburgh, Old Surgeons Hall, High School Yards, Edinburgh EH1 1LZ, UK
3 shared publications - Joanna Chataway
ESRC Innogen Centre, Development Policy and Practice, Open University, UK
2 shared publications Aidan Courtney
Roslin Cells Ltd., Roslin, Midlothian, UK
1 shared publicationAlan Raybould
School of Social and Political Science, Innogen Institute, The University of Edinburgh, Old Surgeons’ Hall, High School Yards, Edinburgh, UK
1 shared publicationAlex Brown
Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK
1 shared publication
Latest Publications
- Open Access
- 4 October 2024
- Published by Elsevier in Trends in Biotechnology
- Vol. 43 (2) , 263-265
Capturing carbon to mitigate climate change: storage or use?
- 4 October 2024
- Published by Elsevier in Trends in Biotechnology
- Vol. 43 (2) , 263-265
Open AccessCapturing carbon to mitigate climate change: storage or use?
- Open Access
- 20 March 2024
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 8 (1) , 16-29
Analysing responsible innovation along a value chain—A single‐cell protein case study
The British Standards Institution's Publicly Available Specification 440 (PAS 440) provides a Responsible Innovation Framework (RIF) that companies can use to continuously monitor the societal, environmental and health benefits and risks of their innovations, as well as relevant changes to the supply chain and regulations. PAS 440 is intended to help companies achieve the benefits of innovation in a timely manner and avoid any potential harm or unintended misuse of a new product, process or service. Here, the authors have applied the PAS 440 RIF to a novel single‐cell protein (SCP) animal feed ingredient taking into consideration the perspectives of the value chain partners (VCPs), companies and laboratories involved in an Innovate UK research project. The authors’ findings show how VCPs can use PAS440 to demonstrate that they are innovating responsibly. Using this approach to responsible innovation along the value chain—from manufacturing scale‐up, through regulatory approval, to incorporation in animal feed and from there to food on supermarket shelves—can support the development of innovations that contribute to the economic and environmental sustainability of the animal feed sector. The authors conclude that the PAS 440 Guide can facilitate the progress of a new product throughout a value chain and contribute to coordinating responsible behaviour among companies involved in the value chain.
- 20 March 2024
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 8 (1) , 16-29
Open AccessAnalysing responsible innovation along a value chain—A single‐cell protein case study
The British Standards Institution's Publicly Available Specification 440 (PAS 440) provides a Responsible Innovation Framework (RIF) that companies can use to continuously monitor the societal, environmental and health benefits and risks of their innovations, as well as relevant changes to the supply chain and regulations. PAS 440 is intended to help companies achieve the benefits of innovation in a timely manner and avoid any potential harm or unintended misuse of a new product, process or service. Here, the authors have applied the PAS 440 RIF to a novel single‐cell protein (SCP) animal feed ingredient taking into consideration the perspectives of the value chain partners (VCPs), companies and laboratories involved in an Innovate UK research project. The authors’ findings show how VCPs can use PAS440 to demonstrate that they are innovating responsibly. Using this approach to responsible innovation along the value chain—from manufacturing scale‐up, through regulatory approval, to incorporation in animal feed and from there to food on supermarket shelves—can support the development of innovations that contribute to the economic and environmental sustainability of the animal feed sector. The authors conclude that the PAS 440 Guide can facilitate the progress of a new product throughout a value chain and contribute to coordinating responsible behaviour among companies involved in the value chain.
- Open Access
- 21 January 2023
- Published by Springer Nature in Circular Economy and Sustainability
- Vol. 3 (4) , 1907-1918
Circular and Networked Bioeconomies for Net-Zero Food Production: There is Nothing Magic About Circles
: Future food production will need to deliver a healthy diet to a growing world population whilst also contributing to policy objectives such as achieving Net Zero emissions and addressing biodiversity loss. This article looks at circular economy solutions to this challenge, comparing McArthur Foundation and other approaches to both the circular material economy (e.g. focusing on steel, plastics, aluminium, and cement) and the circular bioeconomy (operating in sectors that include agriculture, food production and industrial biotechnology). A case study based on salmon farming in Scotland considers the roles of innovation from a range of technology sectors in contributing to these objectives. The concept of circularity, and the closed-loop thinking that it encourages, could attract attention towards less optimal production options just because they can be accommodated within a circular model. A ‘networked bioeconomy’ model, guided by cascading principles and fast-tracked using innovative technologies, may be more powerful than one based on rigid closed-loop circularity, in enabling policy makers and producers to understand how they can best contribute both to the conservation of biodiversity and to mitigating climate change.
- 21 January 2023
- Published by Springer Nature in Circular Economy and Sustainability
- Vol. 3 (4) , 1907-1918
Open AccessCircular and Networked Bioeconomies for Net-Zero Food Production: There is Nothing Magic About Circles
: Future food production will need to deliver a healthy diet to a growing world population whilst also contributing to policy objectives such as achieving Net Zero emissions and addressing biodiversity loss. This article looks at circular economy solutions to this challenge, comparing McArthur Foundation and other approaches to both the circular material economy (e.g. focusing on steel, plastics, aluminium, and cement) and the circular bioeconomy (operating in sectors that include agriculture, food production and industrial biotechnology). A case study based on salmon farming in Scotland considers the roles of innovation from a range of technology sectors in contributing to these objectives. The concept of circularity, and the closed-loop thinking that it encourages, could attract attention towards less optimal production options just because they can be accommodated within a circular model. A ‘networked bioeconomy’ model, guided by cascading principles and fast-tracked using innovative technologies, may be more powerful than one based on rigid closed-loop circularity, in enabling policy makers and producers to understand how they can best contribute both to the conservation of biodiversity and to mitigating climate change.
- Open Access
- 9 July 2021
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 34 (11) , 1249-1262
Creating an innovation ecosystem for rapid diagnostic tests for livestock to support sustainable antibiotic use
Antimicrobial resistance (AMR) is one of today’s greatest public health threats and reducing antimicrobial use in livestock is essential to prevent its spread, requiring rapid diagnostic tests (RDTs) to ensure that the drug prescribed matches the sensitivity of the disease organism. However, despite decades of research on RDTs and a relatively permissive regulatory environment in the UK, few devices are in commercial use. Challenges discussed by RDT developers included identifying commercially-viable targets, and management of the innovation ecosystem, e.g. to create clear pathways to market supporting positive interactions between farmers, vets, and other actors along the value chain. Future support for RDT development could be provided through incorporation in: assured food systems; business service packages provided by centralised laboratories; or animal health monitoring packages related to the spread of AMR. Breeding stock sales could require an accompanying health package including RDTs, vaccines and/or antibiotics, linking to precision agriculture approaches. Unlike the example of RDT development for COVID-19, it seems that the urgency of the issue and the clarity of links between animal and human health outcomes are not yet sufficient to support a fast-tracking programme for the development of RDTs to combat AMR.
- 9 July 2021
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 34 (11) , 1249-1262
Open AccessCreating an innovation ecosystem for rapid diagnostic tests for livestock to support sustainable antibiotic use
Antimicrobial resistance (AMR) is one of today’s greatest public health threats and reducing antimicrobial use in livestock is essential to prevent its spread, requiring rapid diagnostic tests (RDTs) to ensure that the drug prescribed matches the sensitivity of the disease organism. However, despite decades of research on RDTs and a relatively permissive regulatory environment in the UK, few devices are in commercial use. Challenges discussed by RDT developers included identifying commercially-viable targets, and management of the innovation ecosystem, e.g. to create clear pathways to market supporting positive interactions between farmers, vets, and other actors along the value chain. Future support for RDT development could be provided through incorporation in: assured food systems; business service packages provided by centralised laboratories; or animal health monitoring packages related to the spread of AMR. Breeding stock sales could require an accompanying health package including RDTs, vaccines and/or antibiotics, linking to precision agriculture approaches. Unlike the example of RDT development for COVID-19, it seems that the urgency of the issue and the clarity of links between animal and human health outcomes are not yet sufficient to support a fast-tracking programme for the development of RDTs to combat AMR.
- Open Access
- 29 March 2021
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 5 (1) , 2-9
Responsible innovation: Its role in an era of technological and regulatory transformation
In the development of innovative technology products, companies of all sizes are being encouraged to innovate responsibly and regulators are encouraged to adapt their regulatory systems to be smarter, more proportionate and adaptive to the needs of innovative technologies. The British Standards Institution Responsible Innovation (RI) Guide (Publicly Available Specification [PAS] 440) is an industry‐wide standard relevant to both these policy trends. It supports companies by providing a framework to demonstrate the balance between the potential benefits and harms and, if necessary, to take action to maximise the benefits and/or minimise the harms. It includes guidance on engagement with stakeholders and will codify what stakeholders can expect from companies undertaking responsible innovation, paving the way to more harmonious relationships among stakeholders with differing interests and values. A cross‐sectoral survey of innovative companies showed that 90% favoured the development of such a standard. PAS 440 was also trialled in two early‐stage biotechnology companies and its expected benefits included contributing to coordinated responsible behaviour along a supply chain; better company and stakeholder understanding of the product properties; supporting decision‐making on whether or not to start a company; considering the risks of not developing the product and avoiding reputational risks. Benefits were expected to be increasingly significant as the RI standard becomes widely adopted.
- 29 March 2021
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 5 (1) , 2-9
Open AccessResponsible innovation: Its role in an era of technological and regulatory transformation
In the development of innovative technology products, companies of all sizes are being encouraged to innovate responsibly and regulators are encouraged to adapt their regulatory systems to be smarter, more proportionate and adaptive to the needs of innovative technologies. The British Standards Institution Responsible Innovation (RI) Guide (Publicly Available Specification [PAS] 440) is an industry‐wide standard relevant to both these policy trends. It supports companies by providing a framework to demonstrate the balance between the potential benefits and harms and, if necessary, to take action to maximise the benefits and/or minimise the harms. It includes guidance on engagement with stakeholders and will codify what stakeholders can expect from companies undertaking responsible innovation, paving the way to more harmonious relationships among stakeholders with differing interests and values. A cross‐sectoral survey of innovative companies showed that 90% favoured the development of such a standard. PAS 440 was also trialled in two early‐stage biotechnology companies and its expected benefits included contributing to coordinated responsible behaviour along a supply chain; better company and stakeholder understanding of the product properties; supporting decision‐making on whether or not to start a company; considering the risks of not developing the product and avoiding reputational risks. Benefits were expected to be increasingly significant as the RI standard becomes widely adopted.
- 17 June 2019
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 33 (3) , 307-319
Policy support for disruptive innovation in the life sciences
This paper focuses on business models and value chains to analyse sectoral innovation systems involving synthetic biology and gene editing, as potentially disruptive platform technologies in the life sciences. In the context of industrial biotechnology, we propose that the extent to which an innovation is expected to be disruptive, and the location of that disruption in existing value chains, are relevant to policy decision making on how to govern innovative technologies. Policy decisions on how to regulate or support an innovative technology will be among the most important factors determining the extent to which it is able to deliver its disruptive potential, leading to sectoral transformations through new business models and value chains. This mode of thinking about disruption and innovation could be incorporated in standard procedures for policy makers to guide decisions designed to support translation from basic scientific research to societally useful products and processes.
- 17 June 2019
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 33 (3) , 307-319
Policy support for disruptive innovation in the life sciences
This paper focuses on business models and value chains to analyse sectoral innovation systems involving synthetic biology and gene editing, as potentially disruptive platform technologies in the life sciences. In the context of industrial biotechnology, we propose that the extent to which an innovation is expected to be disruptive, and the location of that disruption in existing value chains, are relevant to policy decision making on how to govern innovative technologies. Policy decisions on how to regulate or support an innovative technology will be among the most important factors determining the extent to which it is able to deliver its disruptive potential, leading to sectoral transformations through new business models and value chains. This mode of thinking about disruption and innovation could be incorporated in standard procedures for policy makers to guide decisions designed to support translation from basic scientific research to societally useful products and processes.
- Open Access
- 18 May 2017
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 1 (1) , 7-11
From responsible research to responsible innovation: challenges in implementation
This study proposes a new approach to the responsible development of innovative products, processes and services by companies and organisations operating in the bioeconomy and related industry sectors. It departs from much of the recent and currently available research on responsible research and innovation in that it recognises the very different challenges faced by innovating organisations, compared to conventional approaches with a strong emphasis on upstream engagement. It attempts to move away from the politicised perspectives that have dominated many engagement initiatives on disruptive innovations like synthetic/engineering biology, and to focus on practical downstream outcomes, the extent to which they will fulfil the aspirations of ordinary citizens, and will comply with prevailing industry norms of responsible behaviour. The proposed consolidated responsible innovation framework builds on the framework developed in 2012 by the then Technology Strategy Board, implemented using the anticipate, reflect, engage and act approach devised by UK research councils. It distinguishes between routine, company‐specific aspects of responsibility, expected to be addressed within an organisation's standard operating procedures, and project‐specific aspects requiring regular appraisal throughout the development of an innovation. It is designed to be simple and feasible for a company to implement within a commercial environment.
- 18 May 2017
- Published by Institution of Engineering and Technology (IET) in Engineering Biology
- Vol. 1 (1) , 7-11
Open AccessFrom responsible research to responsible innovation: challenges in implementation
This study proposes a new approach to the responsible development of innovative products, processes and services by companies and organisations operating in the bioeconomy and related industry sectors. It departs from much of the recent and currently available research on responsible research and innovation in that it recognises the very different challenges faced by innovating organisations, compared to conventional approaches with a strong emphasis on upstream engagement. It attempts to move away from the politicised perspectives that have dominated many engagement initiatives on disruptive innovations like synthetic/engineering biology, and to focus on practical downstream outcomes, the extent to which they will fulfil the aspirations of ordinary citizens, and will comply with prevailing industry norms of responsible behaviour. The proposed consolidated responsible innovation framework builds on the framework developed in 2012 by the then Technology Strategy Board, implemented using the anticipate, reflect, engage and act approach devised by UK research councils. It distinguishes between routine, company‐specific aspects of responsibility, expected to be addressed within an organisation's standard operating procedures, and project‐specific aspects requiring regular appraisal throughout the development of an innovation. It is designed to be simple and feasible for a company to implement within a commercial environment.
- Open Access
- 3 June 2013
- Published by Wiley in New Phytologist
- Vol. 200 (1) , 13-15
Building foundations for an open perspective on synthetic biology research and innovation
- 3 June 2013
- Published by Wiley in New Phytologist
- Vol. 200 (1) , 13-15
Open AccessBuilding foundations for an open perspective on synthetic biology research and innovation
- Open Access
- 1 June 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (7) , 579
Adaptive governance of synthetic biology
Synthetic biology has the potential to revolutionize the development of drugs, vaccines, biofuels and food crops, and to clean up environmental pollution, but the field is relatively young. It is too early to tell how it will deliver new fundamental understandings in the life sciences, how this understanding will create opportunities for innovation to satisfy human needs and the extent to which its applications might generate hazards to people or the environment. Synthetic biology is now being linked by NGOs to genetically modified (GM)crop development with potentially similar results for its future development [[1]]. An NGO advocacy coalition has published a report on synthetic biology that echoes the arguments made against GM crops in the late 1990s [[2]] with the intention to “… reign [sic] in these new technologies”, with an ideologically based framing of the technology as inherently hazardous, based on negative conjectures with little relationship …
- 1 June 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (7) , 579
Open AccessAdaptive governance of synthetic biology
Synthetic biology has the potential to revolutionize the development of drugs, vaccines, biofuels and food crops, and to clean up environmental pollution, but the field is relatively young. It is too early to tell how it will deliver new fundamental understandings in the life sciences, how this understanding will create opportunities for innovation to satisfy human needs and the extent to which its applications might generate hazards to people or the environment. Synthetic biology is now being linked by NGOs to genetically modified (GM)crop development with potentially similar results for its future development [[1]]. An NGO advocacy coalition has published a report on synthetic biology that echoes the arguments made against GM crops in the late 1990s [[2]] with the intention to “… reign [sic] in these new technologies”, with an ideologically based framing of the technology as inherently hazardous, based on negative conjectures with little relationship …
- Open Access
- 15 July 2011
- Published by Springer Nature in EMBO Reports
- Vol. 12 (8) , 763-768
Global food security and the governance of modern biotechnologies
Food security has become a serious issue for governments around the world. Europe stands to have a key role, but the European Union will need to change its policies on plant biotechnology to do so.
- 15 July 2011
- Published by Springer Nature in EMBO Reports
- Vol. 12 (8) , 763-768
Open AccessGlobal food security and the governance of modern biotechnologies
Food security has become a serious issue for governments around the world. Europe stands to have a key role, but the European Union will need to change its policies on plant biotechnology to do so.